Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

QNRX Quoin Pharmaceuticals Ltd

0,5975

0,0074 (1,25%)

Zuletzt aktualisiert: 21:04:40

Verzögert um 15 Minuten

Form S-1 - General form for registration of securities under the Securities Act of 1933

Article too big to display. Click here to view on the SEC website

Quoin Pharmaceuticals (NASDAQ:QNRX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Quoin Pharmaceuticals Charts.

Quoin Pharmaceuticals (NASDAQ:QNRX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Quoin Pharmaceuticals Charts.

News Quoin Pharmaceuticals Ltd

Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference
Dienstag 25 Juni 2024 (23 Stunden vor) • GlobeNewswire Inc.

Quoin Pharmaceuticals Announces Signing of Research Agreement with University College Cork (UCC), Ireland
Mittwoch 12 Juni 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]
Freitag 10 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial Results
Donnerstag 9 Mai 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]
Mittwoch 8 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024
Donnerstag 2 Mai 2024 (2 Monate vor) • GlobeNewswire Inc.

Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results
Mittwoch 13 März 2024 (3 Monate vor) • GlobeNewswire Inc.

Mixed Futures Amidst Quiet Economic Schedule; Oil Prices Climb
Mittwoch 13 März 2024 (3 Monate vor) • IH Market News

Form 424B3 - Prospectus [Rule 424(b)(3)]
Freitag 8 März 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Freitag 8 März 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 8 März 2024 (4 Monate vor) • Edgar (US Regulatory)

Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET
Donnerstag 7 März 2024 (4 Monate vor) • GlobeNewswire Inc.

Weitere Quoin Pharmaceuticals Ltd News-Artikel

Range River Gold

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen